-
1
-
-
85080839015
-
The dynamic roles of TGF-beta in cancer
-
Meulmeester E, Ten DP. The dynamic roles of TGF-beta in cancer. J Pathol 2011, 223:205-218.
-
(2011)
J Pathol
, vol.223
, pp. 205-218
-
-
Meulmeester, E.1
Ten, D.P.2
-
2
-
-
30944444113
-
Alterations in components of the TGF-beta superfamily signaling pathways in human cancer
-
10.1016/j.cytogfr.2005.09.009, 16310402
-
Levy L, Hill CS. Alterations in components of the TGF-beta superfamily signaling pathways in human cancer. Cytokine Growth Factor Rev 2006, 17:41-58. 10.1016/j.cytogfr.2005.09.009, 16310402.
-
(2006)
Cytokine Growth Factor Rev
, vol.17
, pp. 41-58
-
-
Levy, L.1
Hill, C.S.2
-
3
-
-
77953406722
-
Epigenetic Targeting of Transforming Growth Factor beta Receptor II and Implications for Cancer Therapy
-
10.4255/mcpharmacol.09.07, 2857646, 20414468
-
Chowdhury S, Ammanamanchi S, Howell GM. Epigenetic Targeting of Transforming Growth Factor beta Receptor II and Implications for Cancer Therapy. Mol Cell Pharmacol 2009, 1:57-70. 10.4255/mcpharmacol.09.07, 2857646, 20414468.
-
(2009)
Mol Cell Pharmacol
, vol.1
, pp. 57-70
-
-
Chowdhury, S.1
Ammanamanchi, S.2
Howell, G.M.3
-
4
-
-
0029878318
-
The type II transforming growth factor-beta receptor as a tumor-suppressor gene
-
10.1097/00001622-199601000-00009, 8868100
-
Brattain MG, Markowitz SD, Willson JK. The type II transforming growth factor-beta receptor as a tumor-suppressor gene. Curr Opin Oncol 1996, 8:49-53. 10.1097/00001622-199601000-00009, 8868100.
-
(1996)
Curr Opin Oncol
, vol.8
, pp. 49-53
-
-
Brattain, M.G.1
Markowitz, S.D.2
Willson, J.K.3
-
5
-
-
77956100350
-
Reduced transforming growth factor-beta receptor II expression in hepatocellular carcinoma correlates with intrahepatic metastasis
-
10.1038/labinvest.2010.105, 20531292
-
Mamiya T, Yamazaki K, Masugi Y, Mori T, Effendi K, Du W, Hibi T, Tanabe M, Ueda M, Takayama T, Sakamoto M. Reduced transforming growth factor-beta receptor II expression in hepatocellular carcinoma correlates with intrahepatic metastasis. Lab Invest 2010, 90:1339-1345. 10.1038/labinvest.2010.105, 20531292.
-
(2010)
Lab Invest
, vol.90
, pp. 1339-1345
-
-
Mamiya, T.1
Yamazaki, K.2
Masugi, Y.3
Mori, T.4
Effendi, K.5
Du, W.6
Hibi, T.7
Tanabe, M.8
Ueda, M.9
Takayama, T.10
Sakamoto, M.11
-
6
-
-
77952896646
-
TGFbeta signalling: a complex web in cancer progression
-
10.1038/nrc2853, 20495575
-
Ikushima H, Miyazono K. TGFbeta signalling: a complex web in cancer progression. Nat Rev Cancer 2010, 10:415-424. 10.1038/nrc2853, 20495575.
-
(2010)
Nat Rev Cancer
, vol.10
, pp. 415-424
-
-
Ikushima, H.1
Miyazono, K.2
-
7
-
-
77951966115
-
Absence of transforming growth factor-beta type II receptor is associated with poorer prognosis in HER2-negative breast tumours
-
10.1093/annonc/mdp518, 19914962
-
Paiva CE, Drigo SA, Rosa FE, Moraes NF, Caldeira JR, Soares FA, Domingues MA, Rogatto SR. Absence of transforming growth factor-beta type II receptor is associated with poorer prognosis in HER2-negative breast tumours. Ann Oncol 2010, 21:734-740. 10.1093/annonc/mdp518, 19914962.
-
(2010)
Ann Oncol
, vol.21
, pp. 734-740
-
-
Paiva, C.E.1
Drigo, S.A.2
Rosa, F.E.3
Moraes, N.F.4
Caldeira, J.R.5
Soares, F.A.6
Domingues, M.A.7
Rogatto, S.R.8
-
8
-
-
84855389885
-
MicroRNA-21 induces stemness by downregulating transforming growth factor beta receptor 2 (TGFbetaR2) in colon cancer cells
-
10.1093/carcin/bgr246, 3276336, 22072622
-
Yu Y, Kanwar SS, Patel BB, Oh PS, Nautiyal J, Sarkar FH, Majumdar AP. MicroRNA-21 induces stemness by downregulating transforming growth factor beta receptor 2 (TGFbetaR2) in colon cancer cells. Carcinogenesis 2012, 33:68-76. 10.1093/carcin/bgr246, 3276336, 22072622.
-
(2012)
Carcinogenesis
, vol.33
, pp. 68-76
-
-
Yu, Y.1
Kanwar, S.S.2
Patel, B.B.3
Oh, P.S.4
Nautiyal, J.5
Sarkar, F.H.6
Majumdar, A.P.7
-
9
-
-
78650626081
-
The molecular biology of head and neck cancer
-
10.1038/nrc2982, 21160525
-
Leemans CR, Braakhuis BJ, Brakenhoff RH. The molecular biology of head and neck cancer. Nat Rev Cancer 2011, 11:9-22. 10.1038/nrc2982, 21160525.
-
(2011)
Nat Rev Cancer
, vol.11
, pp. 9-22
-
-
Leemans, C.R.1
Braakhuis, B.J.2
Brakenhoff, R.H.3
-
10
-
-
84905388203
-
Androgen receptor and microRNA-21 axis downregulates transforming growth factor beta receptor II (TGFBR2) expression in prostate cancer
-
Mishra S, Deng JJ, Gowda PS, Rao MK, Lin CL, Chen CL, Huang T, Sun LZ. Androgen receptor and microRNA-21 axis downregulates transforming growth factor beta receptor II (TGFBR2) expression in prostate cancer. Oncogene 2013,
-
(2013)
Oncogene
-
-
Mishra, S.1
Deng, J.J.2
Gowda, P.S.3
Rao, M.K.4
Lin, C.L.5
Chen, C.L.6
Huang, T.7
Sun, L.Z.8
-
11
-
-
33947121581
-
TGFBR2 mutation is correlated with CpG island methylator phenotype in microsatellite instability-high colorectal cancer
-
10.1016/j.humpath.2006.10.005, 17270239
-
Ogino S, Kawasaki T, Ogawa A, Kirkner GJ, Loda M, Fuchs CS. TGFBR2 mutation is correlated with CpG island methylator phenotype in microsatellite instability-high colorectal cancer. Hum Pathol 2007, 38:614-620. 10.1016/j.humpath.2006.10.005, 17270239.
-
(2007)
Hum Pathol
, vol.38
, pp. 614-620
-
-
Ogino, S.1
Kawasaki, T.2
Ogawa, A.3
Kirkner, G.J.4
Loda, M.5
Fuchs, C.S.6
-
12
-
-
0035870280
-
Epigenetic patterns in the progression of esophageal adenocarcinoma
-
Eads CA, Lord RV, Wickramasinghe K, Long TI, Kurumboor SK, Bernstein L, Peters JH, DeMeester SR, DeMeester TR, Skinner KA, Laird PW. Epigenetic patterns in the progression of esophageal adenocarcinoma. Cancer Res 2001, 61:3410-3418.
-
(2001)
Cancer Res
, vol.61
, pp. 3410-3418
-
-
Eads, C.A.1
Lord, R.V.2
Wickramasinghe, K.3
Long, T.I.4
Kurumboor, S.K.5
Bernstein, L.6
Peters, J.H.7
DeMeester, S.R.8
DeMeester, T.R.9
Skinner, K.A.10
Laird, P.W.11
-
13
-
-
84858163331
-
Microbiomic subprofiles and MDR1 promoter methylation in head and neck squamous cell carcinoma
-
10.1093/hmg/ddr593, 3298279, 22180460
-
Bebek G, Bennett KL, Funchain P, Campbell R, Seth R, Scharpf J, Burkey B, Eng C. Microbiomic subprofiles and MDR1 promoter methylation in head and neck squamous cell carcinoma. Hum Mol Genet 2012, 21:1557-1565. 10.1093/hmg/ddr593, 3298279, 22180460.
-
(2012)
Hum Mol Genet
, vol.21
, pp. 1557-1565
-
-
Bebek, G.1
Bennett, K.L.2
Funchain, P.3
Campbell, R.4
Seth, R.5
Scharpf, J.6
Burkey, B.7
Eng, C.8
-
14
-
-
20444467290
-
A microRNA polycistron as a potential human oncogene
-
10.1038/nature03552, 15944707
-
He L, Thomson JM, Hemann MT, Hernando-Monge E, Mu D, Goodson S, Powers S, Cordon-Cardo C, Lowe SW, Hannon GJ, Hammond SM. A microRNA polycistron as a potential human oncogene. Nature 2005, 435:828-833. 10.1038/nature03552, 15944707.
-
(2005)
Nature
, vol.435
, pp. 828-833
-
-
He, L.1
Thomson, J.M.2
Hemann, M.T.3
Hernando-Monge, E.4
Mu, D.5
Goodson, S.6
Powers, S.7
Cordon-Cardo, C.8
Lowe, S.W.9
Hannon, G.J.10
Hammond, S.M.11
-
15
-
-
33748302836
-
Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster
-
10.1038/ng1855, 2669546, 16878133
-
Dews M, Homayouni A, Yu D, Murphy D, Sevignani C, Wentzel E, Furth EE, Lee WM, Enders GH, Mendell JT, Thomas-Tikhonenko A. Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster. Nat Genet 2006, 38:1060-1065. 10.1038/ng1855, 2669546, 16878133.
-
(2006)
Nat Genet
, vol.38
, pp. 1060-1065
-
-
Dews, M.1
Homayouni, A.2
Yu, D.3
Murphy, D.4
Sevignani, C.5
Wentzel, E.6
Furth, E.E.7
Lee, W.M.8
Enders, G.H.9
Mendell, J.T.10
Thomas-Tikhonenko, A.11
-
16
-
-
66049112674
-
Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening
-
10.1136/gut.2008.167817, 19201770
-
Ng EK, Chong WW, Jin H, Lam EK, Shin VY, Yu J, Poon TC, Ng SS, Sung JJ. Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. Gut 2009, 58:1375-1381. 10.1136/gut.2008.167817, 19201770.
-
(2009)
Gut
, vol.58
, pp. 1375-1381
-
-
Ng, E.K.1
Chong, W.W.2
Jin, H.3
Lam, E.K.4
Shin, V.Y.5
Yu, J.6
Poon, T.C.7
Ng, S.S.8
Sung, J.J.9
-
17
-
-
81855194117
-
MiR-92 is a key oncogenic component of the miR-17-92 cluster in colon cancer
-
10.1111/j.1349-7006.2011.02081.x, 21883694
-
Tsuchida A, Ohno S, Wu W, Borjigin N, Fujita K, Aoki T, Ueda S, Takanashi M, Kuroda M. miR-92 is a key oncogenic component of the miR-17-92 cluster in colon cancer. Cancer Sci 2011, 102:2264-2271. 10.1111/j.1349-7006.2011.02081.x, 21883694.
-
(2011)
Cancer Sci
, vol.102
, pp. 2264-2271
-
-
Tsuchida, A.1
Ohno, S.2
Wu, W.3
Borjigin, N.4
Fujita, K.5
Aoki, T.6
Ueda, S.7
Takanashi, M.8
Kuroda, M.9
-
18
-
-
79959913677
-
MicroRNA sequence and expression analysis in breast tumors by deep sequencing
-
10.1158/0008-5472.CAN-11-0608, 3129492, 21586611
-
Farazi TA, Horlings HM, Ten HJ, Mihailovic A, Halfwerk H, Morozov P, Brown M, Hafner M, Reyal F, van Kouwenhove M, Kreike B, Sie D, Hovestadt V, Wessels LF, van de Vijver MJ, Tuschl T. MicroRNA sequence and expression analysis in breast tumors by deep sequencing. Cancer Res 2011, 71:4443-4453. 10.1158/0008-5472.CAN-11-0608, 3129492, 21586611.
-
(2011)
Cancer Res
, vol.71
, pp. 4443-4453
-
-
Farazi, T.A.1
Horlings, H.M.2
Ten, H.J.3
Mihailovic, A.4
Halfwerk, H.5
Morozov, P.6
Brown, M.7
Hafner, M.8
Reyal, F.9
van Kouwenhove, M.10
Kreike, B.11
Sie, D.12
Hovestadt, V.13
Wessels, L.F.14
van de Vijver, M.J.15
Tuschl, T.16
-
19
-
-
70449124423
-
Protein lysate microarray analysis to identify microRNAs regulating estrogen receptor signaling in breast cancer cell lines
-
10.1038/onc.2009.241, 19684618
-
Leivonen SK, Makela R, Ostling P, Kohonen P, Haapa-Paananen S, Kleivi K, Enerly E, Aakula A, Hellstrom K, Sahlberg N, Kristensen VN, Borresen-Dale AL, Saviranta P, Perala M, Kallioniemi O. Protein lysate microarray analysis to identify microRNAs regulating estrogen receptor signaling in breast cancer cell lines. Oncogene 2009, 28:3926-3936. 10.1038/onc.2009.241, 19684618.
-
(2009)
Oncogene
, vol.28
, pp. 3926-3936
-
-
Leivonen, S.K.1
Makela, R.2
Ostling, P.3
Kohonen, P.4
Haapa-Paananen, S.5
Kleivi, K.6
Enerly, E.7
Aakula, A.8
Hellstrom, K.9
Sahlberg, N.10
Kristensen, V.N.11
Borresen-Dale, A.L.12
Saviranta, P.13
Perala, M.14
Kallioniemi, O.15
-
20
-
-
77952360640
-
MicroRNA 17/20 inhibits cellular invasion and tumor metastasis in breast cancer by heterotypic signaling
-
10.1073/pnas.1002080107, 2889540, 20406904
-
Yu Z, Willmarth NE, Zhou J, Katiyar S, Wang M, Liu Y, McCue PA, Quong AA, Lisanti MP, Pestell RG. microRNA 17/20 inhibits cellular invasion and tumor metastasis in breast cancer by heterotypic signaling. Proc Natl Acad Sci U S A 2010, 107:8231-8236. 10.1073/pnas.1002080107, 2889540, 20406904.
-
(2010)
Proc Natl Acad Sci U S A
, vol.107
, pp. 8231-8236
-
-
Yu, Z.1
Willmarth, N.E.2
Zhou, J.3
Katiyar, S.4
Wang, M.5
Liu, Y.6
McCue, P.A.7
Quong, A.A.8
Lisanti, M.P.9
Pestell, R.G.10
-
21
-
-
84871246002
-
The miR-106b-25 cluster targets Smad7, activates TGF-beta signaling, and induces EMT and tumor initiating cell characteristics downstream of Six1 in human breast cancer
-
10.1038/onc.2012.11, 3342483, 22286770
-
Smith AL, Iwanaga R, Drasin DJ, Micalizzi DS, Vartuli RL, Tan AC, Ford HL. The miR-106b-25 cluster targets Smad7, activates TGF-beta signaling, and induces EMT and tumor initiating cell characteristics downstream of Six1 in human breast cancer. Oncogene 2012, 31:5162-5171. 10.1038/onc.2012.11, 3342483, 22286770.
-
(2012)
Oncogene
, vol.31
, pp. 5162-5171
-
-
Smith, A.L.1
Iwanaga, R.2
Drasin, D.J.3
Micalizzi, D.S.4
Vartuli, R.L.5
Tan, A.C.6
Ford, H.L.7
-
22
-
-
34248200155
-
MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma
-
10.1038/sj.onc.1210228, 17237814
-
Szafranska AE, Davison TS, John J, Cannon T, Sipos B, Maghnouj A, Labourier E, Hahn SA. MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma. Oncogene 2007, 26:4442-4452. 10.1038/sj.onc.1210228, 17237814.
-
(2007)
Oncogene
, vol.26
, pp. 4442-4452
-
-
Szafranska, A.E.1
Davison, T.S.2
John, J.3
Cannon, T.4
Sipos, B.5
Maghnouj, A.6
Labourier, E.7
Hahn, S.A.8
-
23
-
-
81955161862
-
Novel diagnostic value of circulating miR-18a in plasma of patients with pancreatic cancer
-
10.1038/bjc.2011.453, 3242609, 22045190
-
Morimura R, Komatsu S, Ichikawa D, Takeshita H, Tsujiura M, Nagata H, Konishi H, Shiozaki A, Ikoma H, Okamoto K, Ochiai T, Taniguchi H, Otsuji E. Novel diagnostic value of circulating miR-18a in plasma of patients with pancreatic cancer. Br J Cancer 2011, 105:1733-1740. 10.1038/bjc.2011.453, 3242609, 22045190.
-
(2011)
Br J Cancer
, vol.105
, pp. 1733-1740
-
-
Morimura, R.1
Komatsu, S.2
Ichikawa, D.3
Takeshita, H.4
Tsujiura, M.5
Nagata, H.6
Konishi, H.7
Shiozaki, A.8
Ikoma, H.9
Okamoto, K.10
Ochiai, T.11
Taniguchi, H.12
Otsuji, E.13
-
24
-
-
77951838369
-
MiR-20a promotes proliferation and invasion by targeting APP in human ovarian cancer cells
-
10.1093/abbs/gmq026, 20458444
-
Fan X, Liu Y, Jiang J, Ma Z, Wu H, Liu T, Liu M, Li X, Tang H. miR-20a promotes proliferation and invasion by targeting APP in human ovarian cancer cells. Acta Biochim Biophys Sin (Shanghai) 2010, 42:318-324. 10.1093/abbs/gmq026, 20458444.
-
(2010)
Acta Biochim Biophys Sin (Shanghai)
, vol.42
, pp. 318-324
-
-
Fan, X.1
Liu, Y.2
Jiang, J.3
Ma, Z.4
Wu, H.5
Liu, T.6
Liu, M.7
Li, X.8
Tang, H.9
-
25
-
-
78650194092
-
Let-7 and miR-17-92: small-sized major players in lung cancer development
-
10.1111/j.1349-7006.2010.01707.x, 20735434
-
Osada H, Takahashi T. let-7 and miR-17-92: small-sized major players in lung cancer development. Cancer Sci 2011, 102:9-17. 10.1111/j.1349-7006.2010.01707.x, 20735434.
-
(2011)
Cancer Sci
, vol.102
, pp. 9-17
-
-
Osada, H.1
Takahashi, T.2
-
26
-
-
84856117899
-
Circulating micro-RNA expression profiles in early stage nonsmall cell lung cancer
-
10.1002/ijc.26153, 3259258, 21544802
-
Heegaard NH, Schetter AJ, Welsh JA, Yoneda M, Bowman ED, Harris CC. Circulating micro-RNA expression profiles in early stage nonsmall cell lung cancer. Int J Cancer 2012, 130:1378-1386. 10.1002/ijc.26153, 3259258, 21544802.
-
(2012)
Int J Cancer
, vol.130
, pp. 1378-1386
-
-
Heegaard, N.H.1
Schetter, A.J.2
Welsh, J.A.3
Yoneda, M.4
Bowman, E.D.5
Harris, C.C.6
-
27
-
-
51349165812
-
Elevated expression of the miR-17-92 polycistron and miR-21 in hepadnavirus-associated hepatocellular carcinoma contributes to the malignant phenotype
-
10.2353/ajpath.2008.080096, 2527078, 18688024
-
Connolly E, Melegari M, Landgraf P, Tchaikovskaya T, Tennant BC, Slagle BL, Rogler LE, Zavolan M, Tuschl T, Rogler CE. Elevated expression of the miR-17-92 polycistron and miR-21 in hepadnavirus-associated hepatocellular carcinoma contributes to the malignant phenotype. Am J Pathol 2008, 173:856-864. 10.2353/ajpath.2008.080096, 2527078, 18688024.
-
(2008)
Am J Pathol
, vol.173
, pp. 856-864
-
-
Connolly, E.1
Melegari, M.2
Landgraf, P.3
Tchaikovskaya, T.4
Tennant, B.C.5
Slagle, B.L.6
Rogler, L.E.7
Zavolan, M.8
Tuschl, T.9
Rogler, C.E.10
-
28
-
-
77951890194
-
Deregulation of miR-92a expression is implicated in hepatocellular carcinoma development
-
10.1111/j.1440-1827.2010.02526.x, 20518884
-
Shigoka M, Tsuchida A, Matsudo T, Nagakawa Y, Saito H, Suzuki Y, Aoki T, Murakami Y, Toyoda H, Kumada T, Bartenschlager R, Kato N, Ikeda M, Takashina T, Tanaka M, Suzuki R, Oikawa K, Takanashi M, Kuroda M. Deregulation of miR-92a expression is implicated in hepatocellular carcinoma development. Pathol Int 2010, 60:351-357. 10.1111/j.1440-1827.2010.02526.x, 20518884.
-
(2010)
Pathol Int
, vol.60
, pp. 351-357
-
-
Shigoka, M.1
Tsuchida, A.2
Matsudo, T.3
Nagakawa, Y.4
Saito, H.5
Suzuki, Y.6
Aoki, T.7
Murakami, Y.8
Toyoda, H.9
Kumada, T.10
Bartenschlager, R.11
Kato, N.12
Ikeda, M.13
Takashina, T.14
Tanaka, M.15
Suzuki, R.16
Oikawa, K.17
Takanashi, M.18
Kuroda, M.19
-
29
-
-
67449102314
-
Role of the miR-106b-25 microRNA cluster in hepatocellular carcinoma
-
10.1111/j.1349-7006.2009.01164.x, 19486339
-
Li Y, Tan W, Neo TW, Aung MO, Wasser S, Lim SG, Tan TM. Role of the miR-106b-25 microRNA cluster in hepatocellular carcinoma. Cancer Sci 2009, 100:1234-1242. 10.1111/j.1349-7006.2009.01164.x, 19486339.
-
(2009)
Cancer Sci
, vol.100
, pp. 1234-1242
-
-
Li, Y.1
Tan, W.2
Neo, T.W.3
Aung, M.O.4
Wasser, S.5
Lim, S.G.6
Tan, T.M.7
-
30
-
-
69449105719
-
MiR-93, miR-98, and miR-197 regulate expression of tumor suppressor gene FUS1
-
10.1158/1541-7786.MCR-08-0507, 2741087, 19671678
-
Du L, Schageman JJ, Subauste MC, Saber B, Hammond SM, Prudkin L, Wistuba II, Ji L, Roth JA, Minna JD, Pertsemlidis A. miR-93, miR-98, and miR-197 regulate expression of tumor suppressor gene FUS1. Mol Cancer Res 2009, 7:1234-1243. 10.1158/1541-7786.MCR-08-0507, 2741087, 19671678.
-
(2009)
Mol Cancer Res
, vol.7
, pp. 1234-1243
-
-
Du, L.1
Schageman, J.J.2
Subauste, M.C.3
Saber, B.4
Hammond, S.M.5
Prudkin, L.6
Wistuba, I.I.7
Ji, L.8
Roth, J.A.9
Minna, J.D.10
Pertsemlidis, A.11
-
31
-
-
76249128792
-
MiR-221 overexpression contributes to liver tumorigenesis
-
10.1073/pnas.0907904107, 2806773, 20018759
-
Pineau P, Volinia S, McJunkin K, Marchio A, Battiston C, Terris B, Mazzaferro V, Lowe SW, Croce CM, Dejean A. miR-221 overexpression contributes to liver tumorigenesis. Proc Natl Acad Sci U S A 2010, 107:264-269. 10.1073/pnas.0907904107, 2806773, 20018759.
-
(2010)
Proc Natl Acad Sci U S A
, vol.107
, pp. 264-269
-
-
Pineau, P.1
Volinia, S.2
McJunkin, K.3
Marchio, A.4
Battiston, C.5
Terris, B.6
Mazzaferro, V.7
Lowe, S.W.8
Croce, C.M.9
Dejean, A.10
-
32
-
-
63249099917
-
Functional links between clustered microRNAs: suppression of cell-cycle inhibitors by microRNA clusters in gastric cancer
-
10.1093/nar/gkp002, 2655672, 19153141
-
Kim YK, Yu J, Han TS, Park SY, Namkoong B, Kim DH, Hur K, Yoo MW, Lee HJ, Yang HK, Kim VN. Functional links between clustered microRNAs: suppression of cell-cycle inhibitors by microRNA clusters in gastric cancer. Nucleic Acids Res 2009, 37:1672-1681. 10.1093/nar/gkp002, 2655672, 19153141.
-
(2009)
Nucleic Acids Res
, vol.37
, pp. 1672-1681
-
-
Kim, Y.K.1
Yu, J.2
Han, T.S.3
Park, S.Y.4
Namkoong, B.5
Kim, D.H.6
Hur, K.7
Yoo, M.W.8
Lee, H.J.9
Yang, H.K.10
Kim, V.N.11
-
33
-
-
84870955164
-
MiR-93 enhances angiogenesis and metastasis by targeting LATS2
-
10.4161/cc.22670, 3552918, 23111389
-
Fang L, Du WW, Yang W, Rutnam ZJ, Peng C, Li H, O'Malley YQ, Askeland RW, Sugg S, Liu M, Mehta T, Deng Z, Yang BB. MiR-93 enhances angiogenesis and metastasis by targeting LATS2. Cell Cycle 2012, 11:4352-4365. 10.4161/cc.22670, 3552918, 23111389.
-
(2012)
Cell Cycle
, vol.11
, pp. 4352-4365
-
-
Fang, L.1
Du, W.W.2
Yang, W.3
Rutnam, Z.J.4
Peng, C.5
Li, H.6
O'Malley, Y.Q.7
Askeland, R.W.8
Sugg, S.9
Liu, M.10
Mehta, T.11
Deng, Z.12
Yang, B.B.13
-
34
-
-
81155158874
-
Repression of human activation induced cytidine deaminase by miR-93 and miR-155
-
10.1186/1471-2407-11-347, 3163633, 21831295
-
Borchert GM, Holton NW, Larson ED. Repression of human activation induced cytidine deaminase by miR-93 and miR-155. BMC Cancer 2011, 11:347. 10.1186/1471-2407-11-347, 3163633, 21831295.
-
(2011)
BMC Cancer
, vol.11
, pp. 347
-
-
Borchert, G.M.1
Holton, N.W.2
Larson, E.D.3
-
35
-
-
79951810604
-
MicroRNA miR-93 promotes tumor growth and angiogenesis by targeting integrin-beta8
-
10.1038/onc.2010.465, 20956944
-
Fang L, Deng Z, Shatseva T, Yang J, Peng C, Du WW, Yee AJ, Ang LC, He C, Shan SW, Yang BB. MicroRNA miR-93 promotes tumor growth and angiogenesis by targeting integrin-beta8. Oncogene 2011, 30:806-821. 10.1038/onc.2010.465, 20956944.
-
(2011)
Oncogene
, vol.30
, pp. 806-821
-
-
Fang, L.1
Deng, Z.2
Shatseva, T.3
Yang, J.4
Peng, C.5
Du, W.W.6
Yee, A.J.7
Ang, L.C.8
He, C.9
Shan, S.W.10
Yang, B.B.11
-
36
-
-
84860335557
-
Involvement of microRNA-93, a new regulator of PTEN/Akt signaling pathway, in regulation of chemotherapeutic drug cisplatin chemosensitivity in ovarian cancer cells
-
10.1016/j.febslet.2012.03.006, 22465665
-
Fu X, Tian J, Zhang L, Chen Y, Hao Q. Involvement of microRNA-93, a new regulator of PTEN/Akt signaling pathway, in regulation of chemotherapeutic drug cisplatin chemosensitivity in ovarian cancer cells. FEBS Lett 2012, 586:1279-1286. 10.1016/j.febslet.2012.03.006, 22465665.
-
(2012)
FEBS Lett
, vol.586
, pp. 1279-1286
-
-
Fu, X.1
Tian, J.2
Zhang, L.3
Chen, Y.4
Hao, Q.5
-
37
-
-
77954941124
-
Identification of microRNA-93 as a novel regulator of vascular endothelial growth factor in hyperglycemic conditions
-
10.1074/jbc.M110.136168, 2906336, 20501654
-
Long J, Wang Y, Wang W, Chang BH, Danesh FR. Identification of microRNA-93 as a novel regulator of vascular endothelial growth factor in hyperglycemic conditions. J Biol Chem 2010, 285:23457-23465. 10.1074/jbc.M110.136168, 2906336, 20501654.
-
(2010)
J Biol Chem
, vol.285
, pp. 23457-23465
-
-
Long, J.1
Wang, Y.2
Wang, W.3
Chang, B.H.4
Danesh, F.R.5
-
38
-
-
55349109615
-
Roles for microRNAs, miR-93 and miR-130b, and tumor protein 53-induced nuclear protein 1 tumor suppressor in cell growth dysregulation by human T-cell lymphotrophic virus 1
-
10.1158/0008-5472.CAN-08-0769, 2596768, 18974142
-
Yeung ML, Yasunaga J, Bennasser Y, Dusetti N, Harris D, Ahmad N, Matsuoka M, Jeang KT. Roles for microRNAs, miR-93 and miR-130b, and tumor protein 53-induced nuclear protein 1 tumor suppressor in cell growth dysregulation by human T-cell lymphotrophic virus 1. Cancer Res 2008, 68:8976-8985. 10.1158/0008-5472.CAN-08-0769, 2596768, 18974142.
-
(2008)
Cancer Res
, vol.68
, pp. 8976-8985
-
-
Yeung, M.L.1
Yasunaga, J.2
Bennasser, Y.3
Dusetti, N.4
Harris, D.5
Ahmad, N.6
Matsuoka, M.7
Jeang, K.T.8
-
39
-
-
84906940663
-
MiR-93-directed downregulation of DAB2 defines a novel oncogenic pathway in lung cancer
-
Du L, Zhao Z, Ma X, Hsiao TH, Chen Y, Young E, Suraokar M, Wistuba I, Minna JD, Pertsemlidis A. miR-93-directed downregulation of DAB2 defines a novel oncogenic pathway in lung cancer. Oncogene 2013,
-
(2013)
Oncogene
-
-
Du, L.1
Zhao, Z.2
Ma, X.3
Hsiao, T.H.4
Chen, Y.5
Young, E.6
Suraokar, M.7
Wistuba, I.8
Minna, J.D.9
Pertsemlidis, A.10
-
40
-
-
48149096682
-
Transcriptional patterns, biomarkers and pathways characterizing nasopharyngeal carcinoma of Southern China
-
10.1186/1479-5876-6-32, 2443113, 18570662
-
Fang W, Li X, Jiang Q, Liu Z, Yang H, Wang S, Xie S, Liu Q, Liu T, Huang J, Xie W, Li Z, Zhao Y, Wang E, Marincola FM, Yao K. Transcriptional patterns, biomarkers and pathways characterizing nasopharyngeal carcinoma of Southern China. J Transl Med 2008, 6:32. 10.1186/1479-5876-6-32, 2443113, 18570662.
-
(2008)
J Transl Med
, vol.6
, pp. 32
-
-
Fang, W.1
Li, X.2
Jiang, Q.3
Liu, Z.4
Yang, H.5
Wang, S.6
Xie, S.7
Liu, Q.8
Liu, T.9
Huang, J.10
Xie, W.11
Li, Z.12
Zhao, Y.13
Wang, E.14
Marincola, F.M.15
Yao, K.16
-
41
-
-
84865626282
-
Evaluation of the prognostic value of TGF-beta superfamily type I receptor and TGF-beta type II receptor expression in nasopharyngeal carcinoma using high-throughput tissue microarrays
-
10.1007/s10735-012-9392-4, 22391627
-
Zhang W, Zeng Z, Fan S, Wang J, Yang J, Zhou Y, Li X, Huang D, Liang F, Wu M, Tang K, Cao L, Li X, Xiong W, Li G. Evaluation of the prognostic value of TGF-beta superfamily type I receptor and TGF-beta type II receptor expression in nasopharyngeal carcinoma using high-throughput tissue microarrays. J Mol Histol 2012, 43:297-306. 10.1007/s10735-012-9392-4, 22391627.
-
(2012)
J Mol Histol
, vol.43
, pp. 297-306
-
-
Zhang, W.1
Zeng, Z.2
Fan, S.3
Wang, J.4
Yang, J.5
Zhou, Y.6
Li, X.7
Huang, D.8
Liang, F.9
Wu, M.10
Tang, K.11
Cao, L.12
Li, X.13
Xiong, W.14
Li, G.15
-
42
-
-
78651411120
-
MiR-26a inhibits cell growth and tumorigenesis of nasopharyngeal carcinoma through repression of EZH2
-
10.1158/0008-5472.CAN-10-1850, 21199804
-
Lu J, He ML, Wang L, Chen Y, Liu X, Dong Q, Chen YC, Peng Y, Yao KT, Kung HF, Li XP. MiR-26a inhibits cell growth and tumorigenesis of nasopharyngeal carcinoma through repression of EZH2. Cancer Res 2011, 71:225-233. 10.1158/0008-5472.CAN-10-1850, 21199804.
-
(2011)
Cancer Res
, vol.71
, pp. 225-233
-
-
Lu, J.1
He, M.L.2
Wang, L.3
Chen, Y.4
Liu, X.5
Dong, Q.6
Chen, Y.C.7
Peng, Y.8
Yao, K.T.9
Kung, H.F.10
Li, X.P.11
-
43
-
-
79957552560
-
Enhancer of Zeste homolog 2 (EZH2) is overexpressed in recurrent nasopharyngeal carcinoma and is regulated by miR-26a, miR-101, and miR-98
-
10.1038/cddis.2010.64, 3035896, 21368858
-
Alajez NM, Shi W, Hui AB, Bruce J, Lenarduzzi M, Ito E, Yue S, O'Sullivan B, Liu FF. Enhancer of Zeste homolog 2 (EZH2) is overexpressed in recurrent nasopharyngeal carcinoma and is regulated by miR-26a, miR-101, and miR-98. Cell Death Dis 2010, 1:e85. 10.1038/cddis.2010.64, 3035896, 21368858.
-
(2010)
Cell Death Dis
, vol.1
-
-
Alajez, N.M.1
Shi, W.2
Hui, A.B.3
Bruce, J.4
Lenarduzzi, M.5
Ito, E.6
Yue, S.7
O'Sullivan, B.8
Liu, F.F.9
-
44
-
-
84873532016
-
MiR-18a promotes malignant progression by impairing microRNA biogenesis in nasopharyngeal carcinoma
-
10.1093/carcin/bgs329, 23097559
-
Luo Z, Dai Y, Zhang L, Jiang C, Li Z, Yang J, McCarthy JB, She X, Zhang W, Ma J, Xiong W, Wu M, Lu J, Li X, Li X, Xiang J, Li G. miR-18a promotes malignant progression by impairing microRNA biogenesis in nasopharyngeal carcinoma. Carcinogenesis 2013, 34:415-425. 10.1093/carcin/bgs329, 23097559.
-
(2013)
Carcinogenesis
, vol.34
, pp. 415-425
-
-
Luo, Z.1
Dai, Y.2
Zhang, L.3
Jiang, C.4
Li, Z.5
Yang, J.6
McCarthy, J.B.7
She, X.8
Zhang, W.9
Ma, J.10
Xiong, W.11
Wu, M.12
Lu, J.13
Li, X.14
Li, X.15
Xiang, J.16
Li, G.17
-
45
-
-
84879384573
-
Loss of connective tissue growth factor as an unfavorable prognosis factor activates miR-18b by PI3K/AKT/C-Jun and C-Myc and promotes cell growth in nasopharyngeal carcinoma
-
10.1038/cddis.2013.153, 3674361, 23681229
-
Yu X, Zhen Y, Yang H, Wang H, Zhou Y, Wang E, Marincola FM, Mai C, Chen Y, Wei H, Song Y, Lyu X, Ye Y, Cai L, Wu Q, Zhao M, Hua S, Fu Q, Zhang Y, Yao K, Liu Z, Li X, Fang W. Loss of connective tissue growth factor as an unfavorable prognosis factor activates miR-18b by PI3K/AKT/C-Jun and C-Myc and promotes cell growth in nasopharyngeal carcinoma. Cell Death Dis 2013, 4:e634. 10.1038/cddis.2013.153, 3674361, 23681229.
-
(2013)
Cell Death Dis
, vol.4
-
-
Yu, X.1
Zhen, Y.2
Yang, H.3
Wang, H.4
Zhou, Y.5
Wang, E.6
Marincola, F.M.7
Mai, C.8
Chen, Y.9
Wei, H.10
Song, Y.11
Lyu, X.12
Ye, Y.13
Cai, L.14
Wu, Q.15
Zhao, M.16
Hua, S.17
Fu, Q.18
Zhang, Y.19
Yao, K.20
Liu, Z.21
Li, X.22
Fang, W.23
more..
-
46
-
-
79952751773
-
MiR-218 suppresses nasopharyngeal cancer progression through downregulation of survivin and the SLIT2-ROBO1 pathway
-
10.1158/0008-5472.CAN-10-2754, 21385904
-
Alajez NM, Lenarduzzi M, Ito E, Hui AB, Shi W, Bruce J, Yue S, Huang SH, Xu W, Waldron J, O'Sullivan B, Liu FF. MiR-218 suppresses nasopharyngeal cancer progression through downregulation of survivin and the SLIT2-ROBO1 pathway. Cancer Res 2011, 71:2381-2391. 10.1158/0008-5472.CAN-10-2754, 21385904.
-
(2011)
Cancer Res
, vol.71
, pp. 2381-2391
-
-
Alajez, N.M.1
Lenarduzzi, M.2
Ito, E.3
Hui, A.B.4
Shi, W.5
Bruce, J.6
Yue, S.7
Huang, S.H.8
Xu, W.9
Waldron, J.10
O'Sullivan, B.11
Liu, F.F.12
-
47
-
-
80054008304
-
MiR-216b suppresses tumor growth and invasion by targeting KRAS in nasopharyngeal carcinoma
-
10.1242/jcs.085050, 21878506
-
Deng M, Tang H, Zhou Y, Zhou M, Xiong W, Zheng Y, Ye Q, Zeng X, Liao Q, Guo X, Li X, Ma J, Li G. miR-216b suppresses tumor growth and invasion by targeting KRAS in nasopharyngeal carcinoma. J Cell Sci 2011, 124:2997-3005. 10.1242/jcs.085050, 21878506.
-
(2011)
J Cell Sci
, vol.124
, pp. 2997-3005
-
-
Deng, M.1
Tang, H.2
Zhou, Y.3
Zhou, M.4
Xiong, W.5
Zheng, Y.6
Ye, Q.7
Zeng, X.8
Liao, Q.9
Guo, X.10
Li, X.11
Ma, J.12
Li, G.13
-
48
-
-
84867397321
-
MiR-663, a microRNA targeting p21 (WAF1/CIP1), promotes the proliferation and tumorigenesis of nasopharyngeal carcinoma
-
10.1038/onc.2011.629, 22249270
-
Yi C, Wang Q, Wang L, Huang Y, Li L, Liu L, Zhou X, Xie G, Kang T, Wang H, Zeng M, Ma J, Zeng Y, Yun JP. MiR-663, a microRNA targeting p21 (WAF1/CIP1), promotes the proliferation and tumorigenesis of nasopharyngeal carcinoma. Oncogene 2012, 31:4421-4433. 10.1038/onc.2011.629, 22249270.
-
(2012)
Oncogene
, vol.31
, pp. 4421-4433
-
-
Yi, C.1
Wang, Q.2
Wang, L.3
Huang, Y.4
Li, L.5
Liu, L.6
Zhou, X.7
Xie, G.8
Kang, T.9
Wang, H.10
Zeng, M.11
Ma, J.12
Zeng, Y.13
Yun, J.P.14
-
49
-
-
79955622634
-
Upregulation of MiR-155 in nasopharyngeal carcinoma is partly driven by LMP1 and LMP2A and downregulates a negative prognostic marker JMJD1A
-
10.1371/journal.pone.0019137, 3082546, 21541331
-
Du ZM, Hu LF, Wang HY, Yan LX, Zeng YX, Shao JY, Ernberg I. Upregulation of MiR-155 in nasopharyngeal carcinoma is partly driven by LMP1 and LMP2A and downregulates a negative prognostic marker JMJD1A. PLoS One 2011, 6:e19137. 10.1371/journal.pone.0019137, 3082546, 21541331.
-
(2011)
PLoS One
, vol.6
-
-
Du, Z.M.1
Hu, L.F.2
Wang, H.Y.3
Yan, L.X.4
Zeng, Y.X.5
Shao, J.Y.6
Ernberg, I.7
-
50
-
-
84863116263
-
MiR-205 determines the radioresistance of human nasopharyngeal carcinoma by directly targeting PTEN
-
10.4161/cc.11.4.19228, 3356830, 22374676
-
Qu C, Liang Z, Huang J, Zhao R, Su C, Wang S, Wang X, Zhang R, Lee MH, Yang H. MiR-205 determines the radioresistance of human nasopharyngeal carcinoma by directly targeting PTEN. Cell Cycle 2012, 11:785-796. 10.4161/cc.11.4.19228, 3356830, 22374676.
-
(2012)
Cell Cycle
, vol.11
, pp. 785-796
-
-
Qu, C.1
Liang, Z.2
Huang, J.3
Zhao, R.4
Su, C.5
Wang, S.6
Wang, X.7
Zhang, R.8
Lee, M.H.9
Yang, H.10
-
51
-
-
84865988855
-
Profiling of Epstein-Barr virus-encoded microRNAs in nasopharyngeal carcinoma reveals potential biomarkers and oncomirs
-
Gourzones C, Jimenez AS, Busson P. Profiling of Epstein-Barr virus-encoded microRNAs in nasopharyngeal carcinoma reveals potential biomarkers and oncomirs. Cancer 2012, 118:4634-4635.
-
(2012)
Cancer
, vol.118
, pp. 4634-4635
-
-
Gourzones, C.1
Jimenez, A.S.2
Busson, P.3
-
52
-
-
34547587877
-
Cell size and invasion in TGF-beta-induced epithelial to mesenchymal transition is regulated by activation of the mTOR pathway
-
10.1083/jcb.200611146, 2064840, 17646396
-
Lamouille S, Derynck R. Cell size and invasion in TGF-beta-induced epithelial to mesenchymal transition is regulated by activation of the mTOR pathway. J Cell Biol 2007, 178:437-451. 10.1083/jcb.200611146, 2064840, 17646396.
-
(2007)
J Cell Biol
, vol.178
, pp. 437-451
-
-
Lamouille, S.1
Derynck, R.2
-
53
-
-
15444372825
-
Type I transforming growth factor beta receptor binds to and activates phosphatidylinositol 3-kinase
-
10.1074/jbc.M413223200, 15657037
-
Yi JY, Shin I, Arteaga CL. Type I transforming growth factor beta receptor binds to and activates phosphatidylinositol 3-kinase. J Biol Chem 2005, 280:10870-10876. 10.1074/jbc.M413223200, 15657037.
-
(2005)
J Biol Chem
, vol.280
, pp. 10870-10876
-
-
Yi, J.Y.1
Shin, I.2
Arteaga, C.L.3
-
54
-
-
84881028557
-
MicroRNA-216a/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer
-
10.1002/hep.26369, 23471579
-
Xia H, Ooi LL, Hui KM. MicroRNA-216a/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer. Hepatology 2013, 58:629-641. 10.1002/hep.26369, 23471579.
-
(2013)
Hepatology
, vol.58
, pp. 629-641
-
-
Xia, H.1
Ooi, L.L.2
Hui, K.M.3
-
55
-
-
67650085171
-
TGF-beta activates Akt kinase through a microRNA-dependent amplifying circuit targeting PTEN
-
10.1038/ncb1897, 2744130, 19543271
-
Kato M, Putta S, Wang M, Yuan H, Lanting L, Nair I, Gunn A, Nakagawa Y, Shimano H, Todorov I, Rossi JJ, Natarajan R. TGF-beta activates Akt kinase through a microRNA-dependent amplifying circuit targeting PTEN. Nat Cell Biol 2009, 11:881-889. 10.1038/ncb1897, 2744130, 19543271.
-
(2009)
Nat Cell Biol
, vol.11
, pp. 881-889
-
-
Kato, M.1
Putta, S.2
Wang, M.3
Yuan, H.4
Lanting, L.5
Nair, I.6
Gunn, A.7
Nakagawa, Y.8
Shimano, H.9
Todorov, I.10
Rossi, J.J.11
Natarajan, R.12
-
56
-
-
53349164136
-
The type I TGF-beta receptor engages TRAF6 to activate TAK1 in a receptor kinase-independent manner
-
10.1038/ncb1780, 18758450
-
Sorrentino A, Thakur N, Grimsby S, Marcusson A, von Bulow V, Schuster N, Zhang S, Heldin CH, Landstrom M. The type I TGF-beta receptor engages TRAF6 to activate TAK1 in a receptor kinase-independent manner. Nat Cell Biol 2008, 10:1199-1207. 10.1038/ncb1780, 18758450.
-
(2008)
Nat Cell Biol
, vol.10
, pp. 1199-1207
-
-
Sorrentino, A.1
Thakur, N.2
Grimsby, S.3
Marcusson, A.4
von Bulow, V.5
Schuster, N.6
Zhang, S.7
Heldin, C.H.8
Landstrom, M.9
-
57
-
-
52049111663
-
TRAF6 mediates Smad-independent activation of JNK and p38 by TGF-beta
-
10.1016/j.molcel.2008.09.002, 2621323, 18922473
-
Yamashita M, Fatyol K, Jin C, Wang X, Liu Z, Zhang YE. TRAF6 mediates Smad-independent activation of JNK and p38 by TGF-beta. Mol Cell 2008, 31:918-924. 10.1016/j.molcel.2008.09.002, 2621323, 18922473.
-
(2008)
Mol Cell
, vol.31
, pp. 918-924
-
-
Yamashita, M.1
Fatyol, K.2
Jin, C.3
Wang, X.4
Liu, Z.5
Zhang, Y.E.6
-
58
-
-
79953030875
-
MicroRNA expression profiling of nasopharyngeal carcinoma
-
Li T, Chen JX, Fu XP, Yang S, Zhang Z, Chen K, Li Y. microRNA expression profiling of nasopharyngeal carcinoma. Oncol Rep 2011, 25:1353-1363.
-
(2011)
Oncol Rep
, vol.25
, pp. 1353-1363
-
-
Li, T.1
Chen, J.X.2
Fu, X.P.3
Yang, S.4
Zhang, Z.5
Chen, K.6
Li, Y.7
-
59
-
-
62549160416
-
MicroRNA deregulation and pathway alterations in nasopharyngeal carcinoma
-
10.1038/sj.bjc.6604948, 2661776, 19293812
-
Chen HC, Chen GH, Chen YH, Liao WL, Liu CY, Chang KP, Chang YS, Chen SJ. MicroRNA deregulation and pathway alterations in nasopharyngeal carcinoma. Br J Cancer 2009, 100:1002-1011. 10.1038/sj.bjc.6604948, 2661776, 19293812.
-
(2009)
Br J Cancer
, vol.100
, pp. 1002-1011
-
-
Chen, H.C.1
Chen, G.H.2
Chen, Y.H.3
Liao, W.L.4
Liu, C.Y.5
Chang, K.P.6
Chang, Y.S.7
Chen, S.J.8
-
60
-
-
78049232281
-
The myc-miR-17 92 axis blunts TGF{beta} signaling and production of multiple TGF{beta}-dependent antiangiogenic factors
-
10.1158/0008-5472.CAN-10-2412, 3007123, 20940405
-
Dews M, Fox JL, Hultine S, Sundaram P, Wang W, Liu YY, Furth E, Enders GH, El-Deiry W, Schelter JM, Cleary MA, Thomas-Tikhonenko A. The myc-miR-17 92 axis blunts TGF{beta} signaling and production of multiple TGF{beta}-dependent antiangiogenic factors. Cancer Res 2010, 70:8233-8246. 10.1158/0008-5472.CAN-10-2412, 3007123, 20940405.
-
(2010)
Cancer Res
, vol.70
, pp. 8233-8246
-
-
Dews, M.1
Fox, J.L.2
Hultine, S.3
Sundaram, P.4
Wang, W.5
Liu, Y.Y.6
Furth, E.7
Enders, G.H.8
El-Deiry, W.9
Schelter, J.M.10
Cleary, M.A.11
Thomas-Tikhonenko, A.12
-
61
-
-
33144490646
-
A microRNA expression signature of human solid tumors defines cancer gene targets
-
10.1073/pnas.0510565103, 1413718, 16461460
-
Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, Prueitt RL, Yanaihara N, Lanza G, Scarpa A, Vecchione A, Negrini M, Harris CC, Croce CM. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A 2006, 103:2257-2261. 10.1073/pnas.0510565103, 1413718, 16461460.
-
(2006)
Proc Natl Acad Sci U S A
, vol.103
, pp. 2257-2261
-
-
Volinia, S.1
Calin, G.A.2
Liu, C.G.3
Ambs, S.4
Cimmino, A.5
Petrocca, F.6
Visone, R.7
Iorio, M.8
Roldo, C.9
Ferracin, M.10
Prueitt, R.L.11
Yanaihara, N.12
Lanza, G.13
Scarpa, A.14
Vecchione, A.15
Negrini, M.16
Harris, C.C.17
Croce, C.M.18
-
62
-
-
84857355139
-
Identification of oncogenic microRNA-17-92/ZBTB4/specificity protein axis in breast cancer
-
10.1038/onc.2011.296, 3288192, 21765466
-
Kim K, Chadalapaka G, Lee SO, Yamada D, Sastre-Garau X, Defossez PA, Park YY, Lee JS, Safe S. Identification of oncogenic microRNA-17-92/ZBTB4/specificity protein axis in breast cancer. Oncogene 2012, 31:1034-1044. 10.1038/onc.2011.296, 3288192, 21765466.
-
(2012)
Oncogene
, vol.31
, pp. 1034-1044
-
-
Kim, K.1
Chadalapaka, G.2
Lee, S.O.3
Yamada, D.4
Sastre-Garau, X.5
Defossez, P.A.6
Park, Y.Y.7
Lee, J.S.8
Safe, S.9
-
63
-
-
84861572492
-
Prognostic value of a microRNA signature in nasopharyngeal carcinoma: a microRNA expression analysis
-
10.1016/S1470-2045(12)70102-X, 22560814
-
Liu N, Chen NY, Cui RX, Li WF, Li Y, Wei RR, Zhang MY, Sun Y, Huang BJ, Chen M, He QM, Jiang N, Chen L, Cho WC, Yun JP, Zeng J, Liu LZ, Li L, Guo Y, Wang HY, Ma J. Prognostic value of a microRNA signature in nasopharyngeal carcinoma: a microRNA expression analysis. Lancet Oncol 2012, 13:633-641. 10.1016/S1470-2045(12)70102-X, 22560814.
-
(2012)
Lancet Oncol
, vol.13
, pp. 633-641
-
-
Liu, N.1
Chen, N.Y.2
Cui, R.X.3
Li, W.F.4
Li, Y.5
Wei, R.R.6
Zhang, M.Y.7
Sun, Y.8
Huang, B.J.9
Chen, M.10
He, Q.M.11
Jiang, N.12
Chen, L.13
Cho, W.C.14
Yun, J.P.15
Zeng, J.16
Liu, L.Z.17
Li, L.18
Guo, Y.19
Wang, H.Y.20
Ma, J.21
more..
-
64
-
-
84888132688
-
Signaling interplay between transforming growth factor-beta receptor and PI3K/AKT pathways in cancer
-
10.1016/j.tibs.2013.10.001, 24239264
-
Zhang L, Zhou F, Ten DP. Signaling interplay between transforming growth factor-beta receptor and PI3K/AKT pathways in cancer. Trends Biochem Sci 2013, 38:612-620. 10.1016/j.tibs.2013.10.001, 24239264.
-
(2013)
Trends Biochem Sci
, vol.38
, pp. 612-620
-
-
Zhang, L.1
Zhou, F.2
Ten, D.P.3
-
65
-
-
33750565444
-
Transforming growth factor beta receptor type II inactivation induces the malignant transformation of intestinal neoplasms initiated by Apc mutation
-
10.1158/0008-5472.CAN-06-0890, 17047044
-
Munoz NM, Upton M, Rojas A, Washington MK, Lin L, Chytil A, Sozmen EG, Madison BB, Pozzi A, Moon RT, Moses HL, Grady WM. Transforming growth factor beta receptor type II inactivation induces the malignant transformation of intestinal neoplasms initiated by Apc mutation. Cancer Res 2006, 66:9837-9844. 10.1158/0008-5472.CAN-06-0890, 17047044.
-
(2006)
Cancer Res
, vol.66
, pp. 9837-9844
-
-
Munoz, N.M.1
Upton, M.2
Rojas, A.3
Washington, M.K.4
Lin, L.5
Chytil, A.6
Sozmen, E.G.7
Madison, B.B.8
Pozzi, A.9
Moon, R.T.10
Moses, H.L.11
Grady, W.M.12
-
66
-
-
0028102935
-
A new staging system for nasopharyngeal carcinoma in China
-
10.1016/0360-3016(94)90307-7, 7961009
-
Min H, Hong M, Ma J, Zhang E, Zheng Q, Zhang J, Zhang J, Zhang F, Su Y, Qiu F. A new staging system for nasopharyngeal carcinoma in China. Int J Radiat Oncol Biol Phys 1994, 30:1037-1042. 10.1016/0360-3016(94)90307-7, 7961009.
-
(1994)
Int J Radiat Oncol Biol Phys
, vol.30
, pp. 1037-1042
-
-
Min, H.1
Hong, M.2
Ma, J.3
Zhang, E.4
Zheng, Q.5
Zhang, J.6
Zhang, J.7
Zhang, F.8
Su, Y.9
Qiu, F.10
-
67
-
-
0032441150
-
Cluster analysis and display of genome-wide expression patterns
-
10.1073/pnas.95.25.14863, 24541, 9843981
-
Eisen MB, Spellman PT, Brown PO, Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A 1998, 95:14863-14868. 10.1073/pnas.95.25.14863, 24541, 9843981.
-
(1998)
Proc Natl Acad Sci U S A
, vol.95
, pp. 14863-14868
-
-
Eisen, M.B.1
Spellman, P.T.2
Brown, P.O.3
Botstein, D.4
-
68
-
-
83655183338
-
The Zfx gene is expressed in human gliomas and is important in the proliferation and apoptosis of the human malignant glioma cell line U251
-
10.1186/1756-9966-30-114, 3259083, 22185393
-
Zhou Y, Su Z, Huang Y, Sun T, Chen S, Wu T, Chen G, Xie X, Li B, Du Z. The Zfx gene is expressed in human gliomas and is important in the proliferation and apoptosis of the human malignant glioma cell line U251. J Exp Clin Cancer Res 2011, 30:114. 10.1186/1756-9966-30-114, 3259083, 22185393.
-
(2011)
J Exp Clin Cancer Res
, vol.30
, pp. 114
-
-
Zhou, Y.1
Su, Z.2
Huang, Y.3
Sun, T.4
Chen, S.5
Wu, T.6
Chen, G.7
Xie, X.8
Li, B.9
Du, Z.10
-
69
-
-
34447115676
-
An imageable metastatic treatment model of nasopharyngeal carcinoma
-
10.1158/1078-0432.CCR-07-0089, 17606730
-
Liu T, Ding Y, Xie W, Li Z, Bai X, Li X, Fang W, Ren C, Wang S, Hoffman RM, Yao K. An imageable metastatic treatment model of nasopharyngeal carcinoma. Clin Cancer Res 2007, 13:3960-3967. 10.1158/1078-0432.CCR-07-0089, 17606730.
-
(2007)
Clin Cancer Res
, vol.13
, pp. 3960-3967
-
-
Liu, T.1
Ding, Y.2
Xie, W.3
Li, Z.4
Bai, X.5
Li, X.6
Fang, W.7
Ren, C.8
Wang, S.9
Hoffman, R.M.10
Yao, K.11
-
70
-
-
79953304328
-
Decreased expression of updated NESG1 in nasopharyngeal carcinoma: its potential role and preliminarily functional mechanism
-
10.1002/ijc.25595, 20715168
-
Liu Z, Li X, He X, Jiang Q, Xie S, Yu X, Zhen Y, Xiao G, Yao K, Fang W. Decreased expression of updated NESG1 in nasopharyngeal carcinoma: its potential role and preliminarily functional mechanism. Int J Cancer 2011, 128:2562-2571. 10.1002/ijc.25595, 20715168.
-
(2011)
Int J Cancer
, vol.128
, pp. 2562-2571
-
-
Liu, Z.1
Li, X.2
He, X.3
Jiang, Q.4
Xie, S.5
Yu, X.6
Zhen, Y.7
Xiao, G.8
Yao, K.9
Fang, W.10
|